Clinical Trial Update: Amendment of rTSST-1 Variant Vaccine Phase 1 Clinical Trial [Phase 1]

View source ↗

Summary

This document reports an amendment to a Phase 1 trial and completion of a study evaluating an rTSST-1 variant vaccine for toxic shock syndrome and sepsis, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Toxic Shock Syndrome

Drugs mentioned

• rTSST-1 Variant Vaccine (rTSST-1 variant vaccine)

Snippet

Sponsor: Biomedizinische Forschungs gmbH | Conditions: Toxic-Shock Syndrome, Sepsis | Phase 1 | Status: COMPLETED | Results posted: 2017-05-08